Cytochrome P-450 CYP3A5 Inhibitors

Known as: Inhibitors, CYP3A5, P450 CYP3A5 Inhibitors, CYP3A5 Inhibitors 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
012320102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Tacrolimus is a potent but expensive first-line immunosuppressant, thus solutions to reduce tacrolimus consumption while maintain… (More)
  • table 2
Is this relevant?
2016
2016
We previously reported that tacrolimus (TAC) trough blood concentrations for African American (AA) kidney allograft recipients… (More)
Is this relevant?
2015
2015
AIMS Sirolimus is an mTOR inhibitor metabolized by CYP3A4 and CYP3A5. Reported effects of CYP3A5 polymorphisms on sirolimus… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
AIMS To assess the efficacy and safety of tacrolimus and cyclosporin A (CsA)-based immunosuppressive regimens in Chinese de novo… (More)
Is this relevant?
2015
2015
BACKGROUND The aim of this work was to evaluate the CYP3A5:CYP3A5*1/CYP3A5*3 (6986A>G) polymorphism related to the… (More)
Is this relevant?
Review
2010
Review
2010
Tacrolimus is a commonly used immunosuppressive agent in renal transplantation. Therapeutic drug monitoring of tacrolimus is… (More)
Is this relevant?